AbBaltis
AbBaltis serves the In Vitro Diagnostics and Biotech markets by offering innovative, reliable, and quality biologically-based products. Their purpose is to supply a wide variety of Disease State Plasma and Residual Clinical Samples with fast global delivery, competitive pricing, outstanding customer support, and a focus on innovation to improve patient lives. The company has a seasoned team of scientists and researchers with industry experience in assay development, diagnostic research, and new market development. AbBaltis is an award-winning company with a history of growth, innovation, and recognition, including a Queen's Award for Enterprise for International Trade in 2015. They are committed to personalized service, quality control, and supporting scientific and medical advancements worldwide.
Industries
Nr. of Employees
small (1-50)
AbBaltis
Products
Disease-state plasma and serum panels
Catalogued panels and individual units of human plasma and serum from donors with defined disease states for use in assay development, QC and production.
Bulk allergy-positive plasma
Bulk panels of allergy-positive plasma suitable for assay development and QC.
Bulk autoimmune disease-state plasma
Bulk autoimmune disease-state plasma for use in research, QC and production.
Bulk infectious disease-state plasma
Bulk infectious disease-state plasma panels for assay development and QC.
Clinical residual samples
Residual clinical specimens available for research, validation and regulatory submission activities.
Product catalogue (downloadable)
Digital product catalogue listing available sample types and panels, available for download.
Disease-state plasma and serum panels
Catalogued panels and individual units of human plasma and serum from donors with defined disease states for use in assay development, QC and production.
Bulk allergy-positive plasma
Bulk panels of allergy-positive plasma suitable for assay development and QC.
Bulk autoimmune disease-state plasma
Bulk autoimmune disease-state plasma for use in research, QC and production.
Bulk infectious disease-state plasma
Bulk infectious disease-state plasma panels for assay development and QC.
Clinical residual samples
Residual clinical specimens available for research, validation and regulatory submission activities.
Product catalogue (downloadable)
Digital product catalogue listing available sample types and panels, available for download.
Services
Processing and preparation of plasma and off-the-clot serum to client specifications, including aliquoting and preparation for shipment.
Services including biomarker identification, proof-of-concept studies and prospective specimen collection under ethical approvals.
Coordination of rapid international shipping for biological samples including customs documentation and use of specialist couriers to maintain cold-chain integrity.
Processing and preparation of plasma and off-the-clot serum to client specifications, including aliquoting and preparation for shipment.
Services including biomarker identification, proof-of-concept studies and prospective specimen collection under ethical approvals.
Coordination of rapid international shipping for biological samples including customs documentation and use of specialist couriers to maintain cold-chain integrity.
Expertise Areas
- Biobanking and sample provision for IVD and research
- Assay support and QC material provision
- Protein purification and downstream process optimisation
- Prospective specimen collection under ethical/IRB oversight
Key Technologies
- Enzyme immunoassays (EIA/ELISA)
- Indirect immunofluorescence assay (IFA)
- Complement fixation (CF)
- Radioimmunoassay (RIA)
News & Updates
AbBaltis marked its 10th anniversary in 2020, expanding facilities and team, and supporting local education. The company anticipates future growth in diagnostics and health solutions.
The company has moved into a new, larger premises in Sittingbourne, Kent, to support growth and improve operational efficiency.
AbBaltis has received numerous awards including the Queen’s Award for Enterprise for International Trade in 2015, and others for innovation and entrepreneurship.
Four team members passed their Sales Foundation Course with flying colors, reflecting the company's commitment to excellence.
Celebrating 14 years of innovation and growth in the In Vitro Diagnostics field, with a focus on future developments and global health challenges.
Reflecting on a decade of growth, including facility expansion, team growth, and contributions to COVID-19 testing solutions.
AbBaltis marked its 10th anniversary in 2020, expanding facilities and team, and supporting local education. The company anticipates future growth in diagnostics and health solutions.
The company has moved into a new, larger premises in Sittingbourne, Kent, to support growth and improve operational efficiency.
AbBaltis has received numerous awards including the Queen’s Award for Enterprise for International Trade in 2015, and others for innovation and entrepreneurship.
Four team members passed their Sales Foundation Course with flying colors, reflecting the company's commitment to excellence.
Celebrating 14 years of innovation and growth in the In Vitro Diagnostics field, with a focus on future developments and global health challenges.
Reflecting on a decade of growth, including facility expansion, team growth, and contributions to COVID-19 testing solutions.